Canada Gazette, Part I, Volume 153, Number 32: GOVERNMENT NOTICES

August 10, 2019

DEPARTMENT OF HEALTH

HAZARDOUS MATERIALS INFORMATION REVIEW ACT

Decisions, undertakings and orders on claims for exemption

Pursuant to paragraph 18(1)(a) of the Hazardous Materials Information Review Act, the Chief Screening Officer hereby gives notice of the decisions of the screening officer respecting each claim for exemption and the relevant safety data sheet (SDS) and (where applicable) the label listed below.

In accordance with section 20 of the Hazardous Materials Information Review Act, a claimant or any affected party, as defined, may appeal a decision or order of a screening officer. An affected party may also appeal an undertaking in respect of which a notice has been published in the Canada Gazette. To initiate the appeal process, a Statement of Appeal (Form 1) as prescribed by the Hazardous Materials Information Review Act Appeal Board Procedures Regulations must be completed and delivered, along with the fee prescribed by section 12 of the Hazardous Materials Information Review Regulations, within 45 days of the publication of this notice in the Canada Gazette, Part I, to the Chief Appeals Officer at the following address: Workplace Hazardous Materials Bureau, 269 Laurier Avenue West, 8th Floor, 4908B, Ottawa, Ontario K1A 0K9.

Véronique Lalonde
Chief Screening Officer

On February 11, 2015, the Hazardous Products Act (HPA) was amended, and the Controlled Products Regulations (CPR) and the Ingredient Disclosure List were repealed and replaced with the new Hazardous Products Regulations (HPR). The revised legislation (HPA/HPR) is referred to as WHMIS 2015.

All claims for exemption in this publication were filed and evaluated in accordance with the provisions of WHMIS 2015.

A Notice of Filing was published in Part I of the Canada Gazette and there were no written representations from affected parties with respect to any of the claims for exemption and related SDSs or labels mentioned below.

Each of the claims for exemption listed in the table below was found to be valid except for Registry Number (RN) 10243, which was found to be partially valid. The screening officer reached this decision after reviewing the information in support of the claim, having regard exclusively to the criteria found in section 3 of the Hazardous Materials Information Review Regulations.

RN

Claimant

Product Identifier

Date of Decision

9135

MacDermid Enthone, Inc.

ALUMON® AE-182

2019-03-28

9601

BYK USA Inc.

NANOBYK-3610

2019-05-13

9720

CES Energy Solutions

Sand Control Chemical

2019-05-22

9721

CES Energy Solutions

EnerScav A

2019-05-10

9836

CES Energy Solutions

EnerMul P-100

2019-06-10

9857

Nalco Canada ULC

NALCO 62950 PLUS

2019-06-04

9863

Nalco Canada ULC

NALCO® 64828

2019-04-26

10008

Innospec Fuel Specialties LLC

OGI-6020

2019-05-10

10016

Nalco Canada ULC

CLAR16730A

2019-06-20

10017

Nalco Canada ULC

NALCO® EC6730A

2019-06-20

10027

Innospec Fuel Specialties LLC

OGI-7680

2019-04-26

10045

Innospec Fuel Specialties LLC

OGI-9010

2019-06-14

10160

Innospec Fuel Specialties LLC

OGI-9993

2019-06-12

10243

Italmatch USA Corporation

Polartech® EA 650 NS

2019-05-03

10245

Italmatch USA Corporation

Polartech® EA 646 NS

2019-05-03

11824

Nalco Canada ULC

NALCO® DVP4V005

2019-06-06

The claimant name on which the screening officer issued a decision for the following claims is different from the claimant name that was published in the Notice of Filing.

RN

Notice of Filing Publication Date

Original Claimant Name

New Claimant Name

9135

2014-04-26

Enthone, Inc.

MacDermid Enthone, Inc.

9720

2016-01-23

Canadian Energy Services

CES Energy Solutions

9721

2016-01-23

Canadian Energy Services

CES Energy Solutions

9836

2016-05-26

Canadian Energy Services

CES Energy Solutions

10243

2016-11-05

Afton Chemical Corporation

Italmatch USA Corporation

10245

2016-11-05

Afton Chemical Corporation

Italmatch USA Corporation

The subject of the claim on which the screening officer issued a decision for the following claims is different from the subject of the claim that was published in the Notice of Filing.

RN

Notice of Filing Publication Date

Original Subject of the Claim

Revised Subject of the Claim

9857

2016-07-30

C.i. and C. of one ingredient
C. of two ingredients

C.i. of one ingredient

11824

2018-01-13

C.i. and C. of one ingredient
C. of two ingredients

C.i. of one ingredient

Note: C.i. = chemical identity and C. = concentration

In all cases where the SDS or the label was determined not to be in compliance with the relevant legislation, pursuant to subsection 16.1(1) of the Hazardous Materials Information Review Act, the claimant was given 30 days to provide the screening officer with a signed undertaking accompanied by the SDS or the label amended as necessary.

Non-compliances that fall outside the scope of what is required to be published in the Canada Gazette are referred to as “administrative non-compliances.”

Please refer to Health Canada’s List of Active Claims for Exemption for a description of “administrative non-compliances” and their associated corrective measures.

CLAIMS FOR WHICH THE SCREENING OFFICER WAS SATISFIED THAT THE CLAIMANT HAD TAKEN THE MEASURES SET OUT IN THE UNDERTAKING

Pursuant to paragraph 18(1)(b) of the Hazardous Materials Information Review Act, the Chief Screening Officer hereby gives notice of information that has been disclosed on the relevant SDS or label in compliance with an undertaking and the date on which the notice referred to in subsection 16.1(3) of the Act was issued.

RN: 9135

Date of compliance undertaking: 2019-05-14

The claimant had been advised to correct administrative non-compliances in the SDS (or label) and had been further advised to amend the SDS (or label) as indicated below.

  1. Disclose the recommended use.
  2. Disclose the Canadian initial supplier identifier.
  3. Disclose the information elements concerning the additional hazard and precautionary statements.
  4. Disclose the applicable common names and synonyms for the ingredients “sodium hydroxide”, “caustic soda” and “ascarite”.
  5. Disclose the actual concentration of the ingredient “sodium hydroxide” or disclose a statement immediately following an HPR-prescribed concentration range to indicate that the actual concentration is withheld as trade secret for this ingredient.
  6. Disclose the product’s boiling range.
  7. Disclose conditions to avoid.
  8. Disclose “2,2,2-trichloroethanol (chlorinated solvent)”, “trichloroethylene (chlorinated solvent)”, “tetrachloroethylene (chlorinated solvent)”, “aluminum”, and “zinc” as incompatible materials.
  9. Disclose the calculated product oral ATE of 3 800 mg/kg (58.8% unknown).
  10. Correct the disclosure of misleading information regarding the LD50 (rat, oral) value for the confidential ingredient “sodium salt”.

RN: 9601

Date of compliance undertaking: 2019-07-08

The claimant had been advised to correct administrative non-compliances in the SDS (or label) and had been further advised to amend the SDS (or label) as indicated below.

  1. Disclose the Canadian initial supplier identifier.
  2. Disclose appropriate first aid measures in the case of “skin contact” and “eye contact”.
  3. Disclose the symptoms and effects, whether acute or delayed.
  4. Disclose the boiling range and the decomposition temperature.
  5. Correct the disclosure of misleading information regarding skin corrosion/irritation.
  6. Correct the disclosure of misleading information regarding hazardous ingredient properties in section 11, “Toxicological Information”.

RN: 9720

Date of compliance undertaking: 2019-06-26

The claimant had been advised to correct administrative non-compliances in the SDS (or label) and had been further advised to amend the SDS (or label) as indicated below.

  1. Disclose the recommended use.
  2. Disclose the Canadian initial supplier identifier.
  3. Disclose an adequate emergency telephone number.
  4. Disclose the additional health hazard classifications of “Reproductive Toxicity – Category 2” and “Specific Target Organ Toxicity – Single Exposure – Category 1 (oral, central nervous system, and kidney)”.
  5. Disclose the information elements concerning the additional hazard and precautionary statements.
  6. Disclose the percent of unknown toxicity of 0% for the calculated product oral ATE value.
  7. Disclose “Other hazards” on the SDS.
  8. Disclose the additional applicable common names and synonyms for the ingredient “ethylene glycol”.
  9. Disclose a first aid statement equivalent to “Remove contact lenses, if present and easy to do”.
  10. Disclose the symptoms and effects, whether acute or delayed.
  11. Disclose the immediate medical attention/special treatment needed for exposure to the product.
  12. Disclose first aid statements equivalent to “Obtain special instructions before use”, “Do not handle until all safety precautions have been read and understood”, and “Store locked up”.
  13. Disclose an ACGIH (TWA, STEL, C) of 10 mg/m3 (aerosol only) exposure limit for the ingredient “ethylene glycol”.
  14. Disclose an adequate product odour.
  15. Disclose the product’s viscosity.
  16. Disclose a sufficient description of the delayed and immediate effects, and chronic effects from short-term and long-term exposure.
  17. Correct the misleading information regarding “Reproductive Toxicity” in section 11 of the SDS.
  18. Disclose the calculated product oral ATE of 1 400 mg/kg (0% unknown), and dermal ATE of 3 000 mg/kg (5% unknown).
  19. Correct the disclosure of misleading information regarding the LD50 (rat, oral) value for the ingredient “ethylene glycol”.

RN: 9721

Date of compliance undertaking: 2019-06-05

The claimant had been advised to correct administrative non-compliances in the SDS (or label) and had been further advised to amend the SDS (or label) as indicated below.

  1. Remove CANUTEC’s emergency telephone number.
  2. Disclose the information elements concerning precautionary statements.
  3. Disclose “Other hazards” on the SDS.
  4. Disclose first aid statements equivalent to “IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing”.
  5. Disclose the symptoms and effects, whether acute or delayed.
  6. Disclose precautions for safe handling equivalent to “Store locked up”.
  7. Disclose the product’s evaporation rate.
  8. Disclose the product’s flammability.
  9. Disclose the product’s vapour pressure.
  10. Disclose the product’s viscosity.
  11. Disclose the calculated product oral ATE of 42 000 mg/kg (45–75% unknown).

RN: 9836

Date of compliance undertaking: 2019-06-28

The claimant had been advised to correct administrative non-compliances in the SDS (or label) and had been further advised to amend the SDS (or label) as indicated below.

  1. Remove CANUTEC’s emergency telephone number.
  2. Disclose “Other hazards” on the SDS.
  3. Disclose the percent of unknown toxicity of 40% for the calculated product inhalation ATE value.
  4. Disclose the information elements concerning the additional hazard and precautionary statements.
  5. Disclose the additional applicable common names and synonyms for the ingredient “distillates (petroleum), straight-run middle”.
  6. Disclose an adequate product odour.
  7. Disclose the product’s flammability.
  8. Disclose the product’s decomposition temperature.
  9. Disclose a sufficient description of the delayed and immediate effects, and chronic effects from short-term and long-term exposure.
  10. Specify which components of the hazard statements and precautionary statements apply.

RN: 9857

Date of compliance undertaking: 2019-07-09

The claimant had been advised to correct administrative non-compliances in the SDS (or label) and had been further advised to amend the SDS (or label) as indicated below.

  1. Disclose the appropriate restrictions on use.
  2. Remove CANUTEC’s emergency telephone number.
  3. Disclose the hazard classification of “Skin Corrosion — Category 1”.
  4. Disclose the information elements concerning the additional hazard and precautionary statements.
  5. Disclose the additional common names and synonyms for the ingredients “2-(2-butoxyethoxy)ethanol” and “lactic acid”.
  6. Disclose the applicable information for “the most important symptoms and effects, whether acute or delayed” under section 4, “First-aid measures”.
  7. Disclose a statement conveying the additional information on section 4 of the SDS.
  8. Disclose an adequate product odour.
  9. Disclose the product’s reactivity.
  10. Disclose the delayed and immediate effects, as well as the chronic effects from short-term and long-term exposure.
  11. Disclose the likely routes of exposure in section 11, “Toxicological Information”.
  12. Specify which components of the hazard and precautionary statements apply.

RN: 9863

Date of compliance undertaking: 2019-05-17

The claimant had been advised to correct administrative non-compliances in the SDS (or label) and had been further advised to amend the SDS (or label) as indicated below.

  1. Remove CANUTEC’s emergency telephone number.
  2. Disclose first aid statements equivalent to “IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing”.
  3. Disclose information on the precautions for firefighters.
  4. Disclose emergency procedures to follow in case of accidental release.
  5. Disclose the product’s reactivity.
  6. Disclose the delayed and immediate effects, as well as the chronic effects from short-term and long-term exposure.
  7. Disclose the likely route of exposure in section 11, “Toxicological Information”.
  8. Specify which components of the hazard and precautionary statements apply.

RN: 10008

Date of compliance undertaking: 2019-06-07

The claimant had been advised to correct administrative non-compliances in the SDS (or label) and had been further advised to amend the SDS (or label) as indicated below.

  1. Remove references to the Controlled Products Regulations from the SDS.
  2. Disclose the information elements concerning the additional hazard and precautionary statements.
  3. Disclose an adequate product odour.
  4. Disclose a boiling range and relative density.
  5. Disclose the likely routes of exposure in section 11, “Toxicological Information”.
  6. Disclose symptoms related to the product classification in section 11, “Toxicological Information”.
  7. Disclose a sufficient description of the delayed and immediate effects, and chronic effects from short-term and long-term exposure.
  8. Disclose the calculated product ATE value.

RN: 10016

Date of compliance undertaking: 2019-07-05

The claimant had been advised to correct administrative non-compliances in the SDS (or label) and had been further advised to amend the SDS (or label) as indicated below.

  1. Disclose an adequate emergency telephone number.
  2. Disclose the most important symptoms and effects, whether acute or delayed.
  3. Disclose the product’s reactivity.
  4. Disclose the delayed and immediate effects, and chronic effects from short-term and long-term exposure.

RN: 10017

Date of compliance undertaking: 2019-07-05

The claimant had been advised to correct administrative non-compliances in the SDS (or label) and had been further advised to amend the SDS (or label) as indicated below.

  1. Disclose an adequate emergency telephone number.
  2. Disclose the most important symptoms and effects, whether acute or delayed.
  3. Disclose the product’s reactivity.
  4. Disclose the delayed and immediate effects, and chronic effects from short-term and long-term exposure.

RN: 10027

Date of compliance undertaking: 2019-05-17

The claimant had been advised to correct administrative non-compliances in the SDS (or label) and had been further advised to amend the SDS (or label) as indicated below.

  1. Disclose the information elements concerning the additional hazard and precautionary statements.
  2. Disclose the product’s boiling range.
  3. Disclose the calculated product oral ATE of 4 700 mg/kg (85% unknown).
  4. Correct the disclosure of misleading information regarding the LD50 (rat, oral) value for the disclosed ingredient “isopropanol”.
  5. Disclose the likely route of exposure in section 11, “Toxicological Information”.
  6. Disclose the symptoms related to the physical, chemical and toxicological characteristics.
  7. Disclose the delayed and immediate effects, as well as the chronic effects from short-term and long-term exposure.

RN: 10045

Date of compliance undertaking: 2019-06-21

The claimant had been advised to correct administrative non-compliances in the SDS (or label) and had been further advised to amend the SDS (or label) as indicated below.

  1. Disclose the information elements concerning the precautionary statement.
  2. Correct the disclosure of misleading information regarding first aid measures.
  3. Correct the misleading information with respect to personal protective equipment in section 6, “Accidental release measures”.
  4. Disclose a sufficient description of the delayed and immediate effects, and chronic effects from short-term and long-term exposure.
  5. Disclose the symptoms related to the physical, chemical and toxicological characteristics.
  6. Disclose the likely routes of exposure in section 11, “Toxicological Information”.
  7. Disclose the correct reference and term with respect to the HPR and the SDS.

RN: 10160

Date of compliance undertaking: 2019-06-27

The claimant had been advised to correct administrative non-compliances in the SDS (or label) and had been further advised to amend the SDS (or label) as indicated below.

  1. Disclose the Canadian initial supplier identifier.
  2. Disclose the applicable information for “Incompatibilities” under section 7, “Handling and storage”.
  3. Disclose an adequate product odour.
  4. Disclose a sufficient description of the delayed and immediate effects, and chronic effects from short-term and long-term exposure.
  5. Disclose the likely routes of exposure in section 11, “Toxicological Information”.
  6. Disclose the symptoms related to the physical, chemical and toxicological characteristics.
  7. Disclose the correct reference and term with respect to the HPR and the SDS.

RN: 10245

Date of compliance undertaking: 2019-06-10

The claimant had been advised to correct administrative non-compliances in the SDS (or label) and had been further advised to amend the SDS (or label) as indicated below.

  1. Disclose the Canadian initial supplier identifier.
  2. Disclose the information elements concerning the additional hazard and precautionary statements.
  3. Disclose a sufficient description of the symptoms and effects, whether acute or delayed.
  4. Disclose the appropriate precautions for safe handling.
  5. Disclose an adequate product odour.
  6. Disclose the product’s boiling range.
  7. Correct the disclosure of misleading information regarding conditions to avoid.

RN: 11824

Date of compliance undertaking: 2019-07-09

The claimant had been advised to correct administrative non-compliances in the SDS (or label) and had been further advised to amend the SDS (or label) as indicated below.

  1. Remove CANUTEC’s emergency telephone number.
  2. Disclose the information elements concerning the additional hazard and precautionary statements.
  3. Disclose the applicable information for “the most important symptoms and effects” under section 4, “First-aid measures”.
  4. Disclose information on the precautions for firefighters.
  5. Disclose statements that convey the applicable information on section 7 of the SDS.
  6. Disclose an adequate product odour.
  7. Disclose the product’s reactivity.
  8. Disclose the delayed and immediate effects, as well as the chronic effects from short-term and long-term exposure.
  9. Specify which components of the hazard and precautionary statements apply.

CLAIMS FOR WHICH THE SCREENING OFFICER ISSUED THE DECISION THAT THE CLAIM FOR EXEMPTION WAS EITHER PARTIALLY VALID OR INVALID

In the case of the following claims, the screening officer issued the decision that the claim for exemption was partially valid.

Pursuant to section 18 of the Hazardous Materials Information Review Act, the Chief Screening Officer hereby gives notice of information that the screening officer ordered to be disclosed on an SDS or a label pursuant to subsection 16(1) and information that has been disclosed on the relevant SDS or label in compliance with an undertaking, and the dates on which the orders and notices referred to in subsection 16.1(3) of the Act were issued.

RN: 10243

Date of compliance undertaking: 2019-06-10

The claimant had been advised to correct administrative non-compliances in the SDS (or label) and had been further advised to amend the SDS (or label) as indicated below.

  1. Disclose the Canadian initial supplier identifier.
  2. Disclose the chemical identity and remove the link between the ingredient “sodium petroleum sulfonates” and the registry number on the SDS.
  3. Disclose the information elements concerning the additional hazard and precautionary statements.
  4. Disclose a sufficient description of the symptoms and effects, whether acute or delayed.
  5. Disclose the appropriate precautions for safe handling.
  6. Disclose an adequate product odour.
  7. Disclose the product’s boiling range.

DEPARTMENT OF INDUSTRY

OFFICE OF THE REGISTRAR GENERAL

Appointments

Name and position

Order in Council

Immigration and Refugee Board

 

Full-time members

 

Bulmer, Mary Krista

2019-1039

Liberman, Ron David

2019-1031

Seyan, Ravninder

2019-1038

Singh, Inderpreet Kaur

2019-1037

Lawless, Daren

2019-1023

Natural Sciences and Engineering Research Council

 

Member

 

Mirasty, Russell B.

2019-1093

Lieutenant Governor of the Province of Saskatchewan

 

Smith, Charles Randall

2019-0355

Royal Canadian Mounted Police External Review Committee

 

Chairperson

 

August 1, 2019

Diane Bélanger
Official Documents Registrar

DEPARTMENT OF INDUSTRY

OFFICE OF THE REGISTRAR GENERAL

Senator called

Her Excellency the Governor General has been pleased to summon to the Senate of Canada, by letters patent under the Great Seal of Canada bearing the date of July 22, 2019:

August 1, 2019

Diane Bélanger
Official Documents Registrar

DEPARTMENT OF PUBLIC SAFETY AND EMERGENCY PREPAREDNESS

CRIMINAL CODE

Designation as fingerprint examiner

Pursuant to subsection 667(5) of the Criminal Code, I hereby designate the following persons of the Delta Police Department as fingerprint examiners:

Ottawa, July 26, 2019

Ellen Burack
Assistant Deputy Minister
Community Safety and Countering Crime Branch

DEPARTMENT OF PUBLIC SAFETY AND EMERGENCY PREPAREDNESS

CRIMINAL CODE

Designation as fingerprint examiner

Pursuant to subsection 667(5) of the Criminal Code, I hereby designate the following person of the Winnipeg Police Service as a fingerprint examiner:

Ottawa, July 26, 2019

Ellen Burack
Assistant Deputy Minister
Community Safety and Countering Crime Branch

OFFICE OF THE SUPERINTENDENT OF FINANCIAL INSTITUTIONS

BANK ACT

Peoples Bank of Canada — Letters patent of incorporation

Notice is hereby given of the issuance, pursuant to section 22 of the Bank Act, of letters patent incorporating Peoples Bank of Canada and, in French, Banque Peoples du Canada, effective July 4, 2019.

July 10, 2019

Jeremy Rudin
Superintendent of Financial Institutions

PRIVY COUNCIL OFFICE

Appointment opportunities

We know that our country is stronger — and our government more effective — when decision-makers reflect Canada’s diversity. The Government of Canada has implemented an appointment process that is transparent and merit-based, strives for gender parity, and ensures that Indigenous peoples and minority groups are properly represented in positions of leadership. We continue to search for Canadians who reflect the values that we all embrace: inclusion, honesty, fiscal prudence, and generosity of spirit. Together, we will build a government as diverse as Canada.

We are equally committed to providing a healthy workplace that supports one’s dignity, self-esteem and the ability to work to one’s full potential. With this in mind, all appointees will be expected to take steps to promote and maintain a healthy, respectful and harassment-free work environment.

The Government of Canada is currently seeking applications from diverse and talented Canadians from across the country who are interested in the following positions.

Current opportunities

The following opportunities for appointments to Governor in Council positions are currently open for applications. Every opportunity is open for a minimum of two weeks from the date of posting on the Governor in Council Appointments website.

Position

Organization

Closing date

President and Chief Executive Officer

Canada Lands Company Limited

 

Board Member (Anticipatory)

Canadian Accessibility Standards Development Organization

 

Chairperson (Anticipatory)

Canadian Accessibility Standards Development Organization

 

Chief Executive Officer (Anticipatory)

Canadian Accessibility Standards Development Organization

 

Vice-Chairperson (Anticipatory)

Canadian Accessibility Standards Development Organization

 

Chairperson

Canadian Dairy Commission

 

Chairperson, Vice-Chairperson and Director

Canadian Energy Regulator

 

Chief Executive Officer

Canadian Energy Regulator

 

Lead Commissioner, Deputy Lead Commissioner and Commissioner

Canadian Energy Regulator

 

Pay Equity Commissioner

Canadian Human Rights Commission

 

President (Chief Executive Officer)

Canadian Tourism Commission

 

Chairperson

Farm Credit Canada

 

Member (appointment to roster)

International Trade and International Investment Dispute Settlement Bodies

 

Auditor General of Canada

Office of the Auditor General

 

Chief Accessibility Officer (Anticipatory)

Office of the Chief Accessibility Officer

 

Chief Executive Officer

Parks Canada

 

Commissioner

Public Service Commission

 

Member and Alternate Member

Renewable Resources Board (Gwich’in)

 

Member and Alternate Member

Renewable Resources Board (Sahtu)